Nyumbani › Leukemia ya Limfosaiti ya Muda Mrefu
Majaribio ya kliniki ya Leukemia ya Limfosaiti ya Muda Mrefu yanayovutia washiriki nchini Marekani
Masomo 120 ya Leukemia ya Limfosaiti ya Muda Mrefu yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- Boston, MAUtafiti 31
- Columbus, OHUtafiti 28
- Durham, NCUtafiti 27
- Washington, DCUtafiti 22
- Seattle, WAUtafiti 20
- Rochester, MNUtafiti 19
- New York City, NYUtafiti 18
- Houston, TXUtafiti 17
- Baldwin Park, CAUtafiti 16
- Milwaukee, WIUtafiti 15
- Chicago, ILUtafiti 14
- Cincinnati, OHUtafiti 14
- Nashville, TNUtafiti 13
- Jacksonville, FLUtafiti 11
- Philadelphia, PAUtafiti 11
- Atlanta, GAUtafiti 11
- Portland, ORUtafiti 10
- Dallas, TXUtafiti 10
- Kansas City, MOUtafiti 10
- Salt Lake City, UTUtafiti 10
- Pittsburgh, PAUtafiti 10
- San Diego, CAUtafiti 10
- Denver, COUtafiti 9
- Charlotte, NCUtafiti 9
- Miami, FLUtafiti 9
- St. Louis, MOUtafiti 8
- Los Angeles, CAUtafiti 8
- Omaha, NEUtafiti 8
- Des Moines, IAUtafiti 8
- Queens, NYUtafiti 8
- Winston-Salem, NCUtafiti 8
- Tampa, FLUtafiti 8
- Minneapolis, MNUtafiti 8
- Cleveland, OHUtafiti 8
- Clifton, NJUtafiti 7
- Cedar Rapids, IAUtafiti 7
- Mountain View, CAUtafiti 7
- Aurora, COUtafiti 7
- Fort Wayne, INUtafiti 7
- Detroit, MIUtafiti 7
Kwa jimbo
- AlabamaUtafiti 7
- ArizonaUtafiti 15
- ArkansasUtafiti 4
- CaliforniaUtafiti 33
- ColoradoUtafiti 17
- ConnecticutUtafiti 4
- DelawareUtafiti 4
- FloridaUtafiti 34
- GeorgiaUtafiti 16
- IdahoUtafiti 4
- IllinoisUtafiti 17
- IndianaUtafiti 12
- IowaUtafiti 10
- KansasUtafiti 6
- KentuckyUtafiti 7
- LouisianaUtafiti 6
- MaineUtafiti 6
- MarylandUtafiti 23
- MassachusettsUtafiti 33
- MichiganUtafiti 12
- MinnesotaUtafiti 29
- MississippiUtafiti 5
- MissouriUtafiti 13
- MontanaUtafiti 7
- NebraskaUtafiti 8
- NevadaUtafiti 6
- New HampshireUtafiti 3
- New JerseyUtafiti 13
- New MexicoUtafiti 3
- New YorkUtafiti 26
- North CarolinaUtafiti 34
- OhioUtafiti 43
- OklahomaUtafiti 4
- OregonUtafiti 16
- PennsylvaniaUtafiti 22
- Rhode IslandUtafiti 6
- South CarolinaUtafiti 5
- South DakotaUtafiti 3
- TennesseeUtafiti 17
- TexasUtafiti 38
- UtahUtafiti 10
- VirginiaUtafiti 12
- WashingtonUtafiti 26
- Wilaya ya ColumbiaUtafiti 4
- WisconsinUtafiti 19
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 110 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT05724121Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
InaajiriHatua 1
Hadi umri 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT01853631Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
InaajiriHatua 3
Umri 65 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07321652Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06863402Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 40 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT05334069A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07582432Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT03516617A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06542250Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT04269902A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT05645107A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06943872Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia
InaajiriHatua 2
Umri 75 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07685717A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT05006716A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07277231A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06846671A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06697184A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06973187Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 110 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT00923507Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
InaajiriHatua 2
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT03986034A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT05947851A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06136559Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT06784167Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT01087333A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
InaajiriHatua 4
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07218341Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT07648264Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.